8-Chloro-2-Chloromethyl-6-Trifluoromethyl-Imidazo[1,2-A]Pyridine
CAS : 182181-31-3
Ref. 3D-FC51678
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- 8-Chloro-2-(chloromethyl)-6-(trifluoromethyl)imidazo[1,2-a]pyridine
- Imidazo[1,2-a]pyridine, 8-chloro-2-(chloromethyl)-6-(trifluoromethyl)-
8-Chloro-2-chloromethyl-6-trifluoromethyl imidazo[1,2-a]pyridine is a benzimidazole derivative that is used in the treatment of prostate cancer. It has been shown to modulate androgen receptor activity. 8-Chloro-2-chloromethyl-6-trifluoromethyl imidazo[1,2-a]pyridine binds to androgen receptor with high affinity and selectivity, resulting in a conformational change that prevents DNA binding by other steroidal hormones. The drug also has been shown to inhibit the growth of prostate cancer cells in culture.